CENTRE HOSPITALIER UNIVERSITAIRE DE DIJON
🇫🇷France
Study of the Impact of HYPOglycaemia on Sarcopenia in CIRrhosis
Not yet recruiting
- Conditions
- Cirrhosis
- First Posted Date
- 2025-04-29
- Last Posted Date
- 2025-04-29
- Lead Sponsor
- Centre Hospitalier Universitaire Dijon
- Target Recruit Count
- 200
- Registration Number
- NCT06948656
- Locations
- 🇫🇷
CHU Dijon Bourgogne, Dijon, France
POlycythemia, Proteins and ErYthropoiesis
Recruiting
- Conditions
- Erythropoiesis
- Interventions
- Biological: Collection of tube bottoms from blood samples taken in the clinic
- First Posted Date
- 2025-04-01
- Last Posted Date
- 2025-04-01
- Lead Sponsor
- Centre Hospitalier Universitaire Dijon
- Target Recruit Count
- 400
- Registration Number
- NCT06905106
- Locations
- 🇫🇷
CHU Dijon Bourgogne, Dijon, France
A Pilot Study to Assess the Feasibility and Acceptability of Newborn Screening Using in Silico Panel-based Solo Genome Sequencing in France
Recruiting
- Conditions
- Newborn Screening Programmes for Rare Diseases
- First Posted Date
- 2025-03-13
- Last Posted Date
- 2025-05-14
- Lead Sponsor
- Centre Hospitalier Universitaire Dijon
- Target Recruit Count
- 5000
- Registration Number
- NCT06875089
- Locations
- 🇫🇷
CHU d'Angers, Angers, France
🇫🇷CHU Dijon Bourgogne, Dijon, France
🇫🇷CHU Hôtel Dieu, Nantes, France
PRODIGE 98 : Randomized, Multicenter Phase 3 Trial of Adjuvant Chemotherapy with Modified FOLFIRINOX Versus Capecitabine or Gemcitabine in Patients with Resected Ampullary Adenocarcinoma
Phase 3
Not yet recruiting
- Conditions
- Ampullary Adenocarcinoma
- Interventions
- Drug: mFOLFORINOXDrug: Capecitabine or gemcitabineBiological: Biological assessmentDiagnostic Test: Paraclinical examinations
- First Posted Date
- 2025-02-07
- Last Posted Date
- 2025-02-07
- Lead Sponsor
- Centre Hospitalier Universitaire Dijon
- Target Recruit Count
- 294
- Registration Number
- NCT06813976
- Locations
- 🇫🇷
CHU Dijon Bourgogne, Dijon, France
A Placebo-controlled Evaluation of Low Dose Lithium Carbonate in Patients with TBR1-related Neurocognitive Disorders
Phase 1
Not yet recruiting
- Conditions
- Proven Pathogenic or Probably Pathogenic TBR1 Variant
- Interventions
- Other: Observation phaseDrug: Lithium treatmentBiological: biological monitoring
- First Posted Date
- 2025-01-15
- Last Posted Date
- 2025-01-15
- Lead Sponsor
- Centre Hospitalier Universitaire Dijon
- Target Recruit Count
- 12
- Registration Number
- NCT06776848
- Locations
- 🇫🇷
CHU Dijon Bourgogne, Dijon, France
Aspirin in Acute Pneumonia in the Elderly: a Multicenter, Double-blind, Randomized, Placebo-controlled Trial.
Phase 3
Not yet recruiting
- Conditions
- Elderly PersonAcute Pneumonia
- Interventions
- Drug: Acetylsalicylic acid/Aspirin (100 mg)Drug: Placebo acetylsalicylic acid (100 mg) / 0.9% sodium chloride
- First Posted Date
- 2025-01-14
- Last Posted Date
- 2025-01-14
- Lead Sponsor
- Centre Hospitalier Universitaire Dijon
- Target Recruit Count
- 600
- Registration Number
- NCT06774846
PRODIGE 90 - (FFCD 2204) Neoadjuvant Dostarlimab with Short Course Radiotherapy in a Watch-and-wait Strategy for Microsatellite Unstable or Mismatch Repair-deficient Locally Advanced Rectal Cancer Patients
Phase 3
Recruiting
- Conditions
- Rectal Adenocarcinoma with Mismatch-repair Deficient (dMMR)/ Microsatellite Instability-high (MSI-H)
- Interventions
- Radiation: radiotherapyBiological: Biological study on circulating tumor DNA (optional for the patient)
- First Posted Date
- 2025-01-07
- Last Posted Date
- 2025-02-18
- Lead Sponsor
- Centre Hospitalier Universitaire Dijon
- Target Recruit Count
- 68
- Registration Number
- NCT06762405
- Locations
- 🇫🇷
CHU Dijon Bourgogne, Dijon, France
Choice of Anticoagulant for Primary Hemostasis Studies with PFA200® (Platelet Function Analyser)
Recruiting
- Conditions
- Hemostasis
- Interventions
- Biological: Sampling of 3 additional BAPA tubes
- First Posted Date
- 2024-12-31
- Last Posted Date
- 2025-01-22
- Lead Sponsor
- Centre Hospitalier Universitaire Dijon
- Target Recruit Count
- 100
- Registration Number
- NCT06753838
- Locations
- 🇫🇷
CHU Dijon Bourgogne, Dijon, France
Implementation of a Tumor Response Assessment Program Integrating the Shared Medical Decision Into the Organ Preservation Strategy for Rectal Cancer Patients
Not Applicable
Recruiting
- Conditions
- Rectal Cancer
- First Posted Date
- 2024-12-18
- Last Posted Date
- 2025-04-09
- Lead Sponsor
- Centre Hospitalier Universitaire Dijon
- Target Recruit Count
- 270
- Registration Number
- NCT06740357
- Locations
- 🇫🇷
CHU Dijon Bourgogne, Dijon, France
SOcioeconomics Status and Post-Intensive Care Syndrome
Not yet recruiting
- Conditions
- Post Intensive Care Syndrome (PICS)
- First Posted Date
- 2024-11-20
- Last Posted Date
- 2024-11-20
- Lead Sponsor
- Centre Hospitalier Universitaire Dijon
- Target Recruit Count
- 180
- Registration Number
- NCT06697236
- Locations
- 🇫🇷
CHU Dijon Bourgogne, Dijon, France
© Copyright 2025. All Rights Reserved by MedPath